The Trump administration’s 2025 drug policy agenda omits cannabis rescheduling, despite earlier signals of support, instead prioritizing fentanyl, border security, and addiction treatment. This omission, coupled with a...more
6/9/2025
/ Biden Administration ,
Cannabis Products ,
DEA ,
Department of Justice (DOJ) ,
Legislative Agendas ,
Marijuana ,
New Legislation ,
Opioid ,
Proposed Legislation ,
Regulatory Reform ,
Trump Administration
Movement on legalizing cannabis inches ahead on a federal level -
Cannabis rescheduling hearings began on January 21, 2025, to evaluate moving cannabis from Schedule I to Schedule III of the Controlled Substances Act as...more
3/28/2025
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Congressional Investigations & Hearings ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Enforcement ,
Hemp ,
Licensing Rules ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Regulatory Agenda ,
THC
The past year for the Illinois cannabis industry revealed continuing tensions and disparity between the rosy picture painted by officials; the reality for businesses on the ground; and the downstream impact to patients and...more
3/18/2025
/ Acquisitions ,
Business Licenses ,
Cannabis-Related Businesses (CRBs) ,
Class Action ,
Dispensaries ,
Hemp Cultivation ,
Hemp Related Businesses ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Mergers ,
Regulatory Requirements ,
Tax Revenues ,
THC
Historic DEA marijuana rescheduling hearing opens, paused until mid-January -
Historic hearings to reconsider marijuana's federal status will start mid-January, as announced by U.S. DEA Judge John Mulrooney II. The focus...more
12/20/2024
/ Administrative Hearings ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
DEA ,
Food and Drug Administration (FDA) ,
Hemp ,
Marijuana ,
Marijuana Related Businesses ,
NIST ,
Proposed Legislation ,
Regulatory Agenda
The moment we have all been waiting for has finally happened. Today, the AP reported that the Drug Enforcement Administration (DEA) has accepted the recommendation of the U.S. Department of Health and Human Services (HHS) to...more
In the next 2 months or so, the Drug Enforcement Agency (DEA) is likely to announce that it will reschedule cannabis under the Controlled Substances Act (CSA) from a Schedule I highly dangerous and addictive drug with no...more
It’s 2024, and while nothing ever stays the same in the world of cannabis, in a lot of ways, 2024 feels just like 2023, and 2022....more
3/15/2024
/ Banking Sector ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Hemp ,
IRS ,
Marijuana ,
Marijuana Related Businesses ,
Popular ,
THC
Since passing recreational cannabis in 2019, Illinois has emerged as one of the largest cannabis markets in the country, with total sales approaching $2 billion in 2023. Adult-use cannabis tax revenue topped that of alcohol,...more